Cannabinoid Receptor Type 2 Agonist, <scp>GW405833</scp>, Reduced the Impacts of <scp>MDA</scp>‐<scp>MB</scp>‐231 Breast Cancer Cells on Bone Cells
This study highlights the therapeutic potential of cannabinoid receptor agonist for treating breast cancer bone metastasis and bone-related complications.
Authors
- Chartinun Chutoe (ORCID: https://orcid.org/0000-0001-5018-2322)
- Ingon Inson (ORCID: https://orcid.org/0000-0002-0778-3613)
- Janjira Kanjanapipak
- Kornkamon Lertsuwan (ORCID: https://orcid.org/0000-0001-7852-1920)
Institutions
- Mahidol University (TH)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/cam4.70709
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Mahidol University
- National Research Council of Thailand
- Faculty of Science, Mahidol University